Recs

2

The CAPS Screen: Defend Your Portfolio With These 5 Stocks

Standard and Poor's research shows that consumer staples, utilities, health care, and financials outperform the market 80%-90% of the time during recessions. As my Foolish colleagues Tim Hanson and Brian Richards point out, this outperformance is due to their reliability and healthy dividend policies.

Among large caps, this strategy held up extremely well during the last recession: Most of the top performers -- a group including Johnson & Johnson (NYSE: JNJ  ) and Procter & Gamble (NYSE: PG  ) -- were defensive dividend payers.

With that in mind, I used our new CAPS screening tool to discover which defensive stocks our 110,000 member CAPS investment community loves most.

These stocks have:

Remember, in the first year for which we have data, CAPS' four-star companies outperformed the market with an average gain of 19%. Five-star stocks did even better.

Company

Share Price

Sector

Market Cap (in billions)

Dividend Yield

Automatic Data Processing (NYSE: ADP  )

$42.4

Services

$22.0

2.8%

Coca-Cola (NYSE: KO  )

$50.34

Consumer Goods

$116.8

2.9%

Merck (NYSE: MRK  )

$36.96

Health Care

$79.2

4.1%

Walgreen (NYSE: WAG  )

$34.19

Retail

$33.9

1.3%

Visa (NYSE: V  )

$73.7

Services

$79.8

0.6%

Data from Motley Fool CAPS and Yahoo! Finance as of July 17.

Of course, screens are merely a first step in the stock-selection process. As Miguel de Cervantes -- whose overly idealistic Don Quixote flails impulsively after unachievable dreams -- reminds us, "Diligence is the mother of good fortune." Come and join us on Motley Fool CAPS to dig into these companies further. Let our 110,000-strong (and counting) CAPS community help you polish your portfolio.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Ilan Moscovitz doesn't own shares in any of the companies mentioned in this article. Johnson & Johnson is an Income Investor selection. Coke is an Inside Value pick. The Motley Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 688287, ~/Articles/ArticleHandler.aspx, 5/25/2012 6:48:42 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:05 PM
PG $62.49 Down -0.08 -0.13%
The Procter & Gamb… CAPS Rating: *****
V $119.37 Down -0.40 -0.33%
Visa, Inc. CAPS Rating: ****
WAG $31.36 Up +0.10 +0.32%
Walgreen Company CAPS Rating: ****
MRK $37.55 Down -0.05 -0.13%
Merck & Co., Inc. CAPS Rating: ****
ADP $52.68 Down -0.47 -0.88%
Automatic Data Pro… CAPS Rating: ****
JNJ $62.51 Down -0.59 -0.94%
Johnson & Johnson CAPS Rating: *****
KO $75.23 Down -0.33 -0.44%
The Coca-Cola Comp… CAPS Rating: *****

Advertisement